Thinking straight about orphan drugs, Part 4.
Nicholas Bagley September 14, 2016
Even if the Orphan Drug Act were working properly, its enormous costs might outweigh its exiguous benefits. But it’s not working properly. Drug manufacturers are
Even if the Orphan Drug Act were working properly, its enormous costs might outweigh its exiguous benefits. But it’s not working properly. Drug manufacturers are
The following originally appeared on The Upshot (copyright 2016, The New York Times Company). Hospitals and many insurance carriers care about patient satisfaction. It especially matters to
Work posted here under copyright © of the authors • Details on the Site Policies page
